Lataa...
Cancer nanomedicine meets immunotherapy: opportunities and challenges
Cancer nanomedicines have shown promise in combination immunotherapy, thus far mostly preclinically but also already in clinical trials. Combining nanomedicines with immunotherapy aims to reinforce the cancer-immunity cycle, via potentiating key steps in the immune reaction cascade, namely antigen r...
Tallennettuna:
| Julkaisussa: | Acta Pharmacol Sin |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Singapore
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470866/ https://ncbi.nlm.nih.gov/pubmed/32555445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0448-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|